Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (191-200 of 308) with videos related to

Pageof 31
Sort By:
Plos One|May 26, 2018
Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis expertsYan Xu, Ashkan Shoamanesh, Sam Schulman, et al.
The New England Journal of Medicine|December 8, 2009
Dabigatran versus warfarin in the treatment of acute venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Journal of Thrombosis and Thrombolysis|February 18, 2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™Martin Feuring, Sam Schulman, Henry Eriksson, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international studySuzanne Murray, Claire McLintock, Patrice Lazure, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTHTobias Tritschler, Noémie Kraaijpoel, Philippe Girard, et al.
BMJ Open|July 6, 2014
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysisLuciane Cruz Lopes, John Eikelboom, Frederick A Spencer, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Thrombosis and Haemostasis|December 13, 2022
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A ReviewRachel Eikelboom, Richard P Whitlock, Renato D Lopes, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 28, 2020
Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation StudyKira MacDougall, James D Douketis, Na Li, et al.
Thrombosis and Haemostasis|May 17, 2013
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patientsRamón Lecumberri, Margarita Marqués, Elena Panizo, et al.
Pageof 31

Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Plos One|May 26, 2018
Correction: Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis expertsYan Xu, Ashkan Shoamanesh, Sam Schulman, et al.
The New England Journal of Medicine|December 8, 2009
Dabigatran versus warfarin in the treatment of acute venous thromboembolismSam Schulman, Clive Kearon, Ajay K Kakkar, et al.
Journal of Thrombosis and Thrombolysis|February 18, 2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™Martin Feuring, Sam Schulman, Henry Eriksson, et al.
Research and Practice in Thrombosis and Haemostasis|October 19, 2019
Needs and challenges among physicians and researchers in thrombosis and hemostasis: Results from an international studySuzanne Murray, Claire McLintock, Patrice Lazure, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2020
Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTHTobias Tritschler, Noémie Kraaijpoel, Philippe Girard, et al.
BMJ Open|July 6, 2014
Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysisLuciane Cruz Lopes, John Eikelboom, Frederick A Spencer, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Thrombosis and Haemostasis|December 13, 2022
How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A ReviewRachel Eikelboom, Richard P Whitlock, Renato D Lopes, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 28, 2020
Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation StudyKira MacDougall, James D Douketis, Na Li, et al.
Thrombosis and Haemostasis|May 17, 2013
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patientsRamón Lecumberri, Margarita Marqués, Elena Panizo, et al.
Pageof 31